BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1014 related articles for article (PubMed ID: 17716385)

  • 21. Mucoactive drugs and multiple applications in pulmonary disease therapy.
    Hocquigny A; Hugerot H; Ghanem R; Haute T; Laurent V; Cogulet V; Montier T
    Eur J Pharm Biopharm; 2024 Jan; 194():110-117. PubMed ID: 38048888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
    Rogers DF
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucus and mucins.
    Rubin BK
    Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucous hypersecretion and relationship to cough.
    Nadel JA
    Pulm Pharmacol Ther; 2013 Oct; 26(5):510-3. PubMed ID: 23434445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forced expiratory technique, directed cough, and autogenic drainage.
    Fink JB
    Respir Care; 2007 Sep; 52(9):1210-21; discussion 1221-3. PubMed ID: 17716387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucoactive drugs for asthma and COPD: any place in therapy?
    Rogers DF
    Expert Opin Investig Drugs; 2002 Jan; 11(1):15-35. PubMed ID: 11772318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The cleaning system of the airways: physiology, pathophysiology and effects of ambroxol].
    Wunderer H; Morgenroth K; Weis G
    Med Monatsschr Pharm; 2009 Feb; 32(2):42-7. PubMed ID: 19263911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosol Medications for Treatment of Mucus Clearance Disorders.
    Rubin BK
    Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
    Puchelle E; de Bentzmann S; Zahm JM
    Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
    Boogaard R; de Jongste JC; Merkus PJ
    Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of tasuldine, a bronchosecretolytic agent, on mucus rheology and clearability and the interaction with acetylcholine in ferrets.
    App EM; Tomkiewicz RP; Hahn HL; Engler H; Vergin H; King M
    Pulm Pharmacol Ther; 1997; 10(5-6):271-6. PubMed ID: 9778490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucoactive medications and airway disease.
    Majima Y
    Paediatr Respir Rev; 2002 Jun; 3(2):104-9. PubMed ID: 12297055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guaifenesin in rhinitis.
    Storms W; Farrar JR
    Curr Allergy Asthma Rep; 2009 Mar; 9(2):101-6. PubMed ID: 19210898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis and other respiratory diseases of impaired mucus clearance.
    Livraghi A; Randell SH
    Toxicol Pathol; 2007 Jan; 35(1):116-29. PubMed ID: 17325980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rheology of bronchial secretions and mucociliary transport (author's transl)].
    Puchelle E; Girard F; Zahm JM
    Bull Eur Physiopathol Respir; 1976; 12(6):771-9. PubMed ID: 1016804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
    Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
    Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of mucus hypersecretion.
    Clarke SW
    Eur J Respir Dis Suppl; 1987; 153():136-44. PubMed ID: 3322858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
    Del Donno M; Olivieri D
    Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.